HK inno.N Future Growth
Future criteria checks 2/6
HK inno.N is forecast to grow earnings and revenue by 20.5% and 6.2% per annum respectively. EPS is expected to grow by 20.6% per annum. Return on equity is forecast to be 6% in 3 years.
Key information
20.5%
Earnings growth rate
20.6%
EPS growth rate
| Pharmaceuticals earnings growth | 31.4% |
| Revenue growth rate | 6.2% |
| Future return on equity | 6.0% |
| Analyst coverage | Good |
| Last updated | 01 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,076,721 | 93,401 | 108,683 | 130,050 | 11 |
| 12/31/2025 | 1,002,407 | 80,239 | 88,200 | 118,036 | 12 |
| 12/31/2024 | 914,841 | 65,384 | 66,429 | 97,370 | 10 |
| 12/31/2023 | 827,225 | 47,065 | 58,600 | 78,256 | 10 |
| 12/31/2022 | 852,931 | 42,840 | 53,833 | 81,986 | 7 |
| 9/30/2022 | 839,627 | 41,491 | 14,556 | 42,613 | N/A |
| 6/30/2022 | 830,095 | 34,807 | 4,154 | 30,706 | N/A |
| 3/31/2022 | 763,160 | 20,425 | -5,797 | 11,201 | N/A |
| 12/31/2021 | 769,786 | 21,345 | -4,701 | 26,796 | N/A |
| 9/30/2021 | 743,845 | 28,391 | 18,593 | 67,922 | N/A |
| 6/30/2021 | 706,482 | 32,016 | 5,750 | 83,515 | N/A |
| 3/31/2021 | 652,477 | 33,123 | -17,680 | 67,594 | N/A |
| 12/31/2020 | 598,447 | 27,897 | -39,483 | 54,106 | N/A |
| 9/30/2020 | 559,669 | 20,597 | -42,551 | 36,523 | N/A |
| 6/30/2020 | 550,292 | 13,822 | -34,260 | 32,044 | N/A |
| 3/31/2020 | 546,465 | 14,105 | 20,657 | 85,280 | N/A |
| 12/31/2019 | 539,908 | 13,217 | 55,902 | 103,074 | N/A |
| 9/30/2019 | 526,288 | 28,683 | 41,165 | 79,366 | N/A |
| 6/30/2019 | 508,364 | 22,210 | 10,922 | 37,602 | N/A |
| 3/31/2019 | 499,108 | 35,832 | -981 | 17,548 | N/A |
| 12/31/2018 | 490,700 | 47,743 | 11,373 | 21,757 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A195940's forecast earnings growth (20.5% per year) is above the savings rate (2.7%).
Earnings vs Market: A195940's earnings (20.5% per year) are forecast to grow slower than the KR market (29.2% per year).
High Growth Earnings: A195940's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: A195940's revenue (6.2% per year) is forecast to grow slower than the KR market (9.1% per year).
High Growth Revenue: A195940's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A195940's Return on Equity is forecast to be low in 3 years time (6%).